[Memantine brakes Alzheimer's dementia. The NMDA antagonist is effective in severe cases, too].
D000203:Activities of Daily Living; D000544:Alzheimer Disease / Q000188:drug therapy*; D000818:Animals; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D000077265:Donepezil; D018492:Dopamine Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D018691:Excitatory Amino Acid Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007189:Indans / Q000008:administration & dosage / Q000627:therapeutic use; D008559:Memantine / Q000008:administration & dosage / Q000627:therapeutic use*; D010880:Piperidines / Q000008:administration & dosage / Q000627:therapeutic use; D010919:Placebos; D016032:Randomized Controlled Trials as Topic; D013997:Time Factors
D002800:Cholinesterase Inhibitors; D018492:Dopamine Antagonists; D018691:Excitatory Amino Acid Antagonists; D007189:Indans; D010880:Piperidines; D010919:Placebos; D000077265:Donepezil; D008559:Memantine